finerenone

ESC 2021: Bayer's Kerendia touts outcomes data as it looks to complement J&J, AZ drugs
Fierce Pharma
Sat, 08/28/21 - 09:02 pm
Bayer
ESC
finerenone
Kerendia
FDA
clinical trials
kidney disease
Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients
Fierce Pharma
Fri, 07/9/21 - 11:58 pm
Bayer
finerenone
Kerendia
kidney disease
heart disease
diabetes
type 2 diabetes
Farxiga
Bayer's near-approval Farxiga rival meets goal in 2nd phase 3
Fierce Biotech
Mon, 05/10/21 - 10:03 am
Bayer
finerenone
Farxiga
clinical trials
cardiovascular disease
myocardial infarction
Bayer faces an uphill fight with finerenone
EP Vantage
Mon, 10/26/20 - 11:13 am
Bayer
diabetic kidney disease
kidney disease
clinical trials
finerenone
Invokana
Farxiga
Bayer drug shown to slow diabetic kidney disease
NASDAQ
Fri, 10/23/20 - 11:04 am
Bayer
clinical trials
diabeteic kidney disease
kidney disease
diabetes
finerenone
Big pharma heads towards important readouts
EP Vantage
Wed, 05/20/20 - 10:22 am
Ozempic
Novo Nordisk
etrolizumab
Roche
Ipatasertib
finerenone
Bayer
filgotinib
Gilead Sciences
Galapagos
Avalglucosidase alfa
Sanofi
Rinvoq
AbbVie
clinical trials
Bayer’s big kidney disease readout approaches
EP Vantage
Tue, 04/21/20 - 12:27 pm
Bayer
finerenone
kidney disease
clinical trials
diabetes
diabetic kidney disease
Bayer heart failure drug cuts deaths in mid-stage trial
Yahoo/Reuters
Mon, 08/31/15 - 08:22 am
Bayer
heart failure
finerenone